AIT reports Phase II data for lung infection candidate

AIT Therapeutics Inc. (Pink:AITB) reported data from nine patients with non-tuberculosis Mycobacterial (NTM) infections in the Phase II NO-NTM

Read the full 198 word article

User Sign In